ImmuPharma plc
IMM.L · LSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£919 | -£919 | -£1,048 | -£1,048 |
| Dep. & Amort. | £14 | £14 | £23 | £23 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £28 | £28 | £28 | £28 |
| Change in WC | £49 | £49 | £148 | £148 |
| Other Non-Cash | -£175 | £326 | -£40 | £404 |
| Operating Cash Flow | -£503 | -£503 | -£446 | -£446 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | £0 | -£1 | -£1 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £6 | £4 | -£189 | -£92 |
| Investing Cash Flow | £6 | £4 | -£190 | -£93 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £2,663 | £0 | £0 | £0 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£1,476 | £594 | £209 | £103 |
| Financing Cash Flow | £1,187 | £594 | £209 | £103 |
| Forex Effect | -£31 | -£15 | £24 | £12 |
| Net Chg. in Cash | £160 | £0 | -£848 | -£1,084 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £237 | £0 | £1,084 | £1,084 |
| End Cash | £397 | £0 | £237 | £0 |
| Free Cash Flow | -£503 | -£503 | -£447 | -£447 |